Generic Health
Generic Health Pty Ltd (trading as Lupin AU), a wholly-owned subsidiary of India's Lupin Limited, supplies generic prescription medicines, specialty injectable products, and over-the-counter brands (Pharmacy Action, Goanna, Minoxidil) to community pharmacies, public and private hospitals, and consumers across Australia and New Zealand.
- Company typePrivate
- Founded2004
- HeadquartersBox Hill, Australia
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Generic Health does
Generic Health Pty Ltd, operating from Box Hill, Victoria and now trading as Lupin AU, is a wholly-owned subsidiary of India's Lupin Limited — one of the world's top ten generic pharmaceutical companies — and is a leading Australia-and-New Zealand-based supplier of generic prescription medicines, specialty injectable products, and over-the-counter (OTC) consumer health brands. The company serves three primary commercial segments: public and private hospitals (supplied via dedicated hospital account managers with injectable and oral generic products), community pharmacies (supplied via pharmacy chains and independents with PBS-listed generic prescriptions and OTC lines), and end consumers (via retail pharmacy channels for OTC lines). Its product ecosystem is organized around four brands: Generic Health (specialty injectables and oral generics), Pharmacy Action (OTC value range launched 2013), Goanna (heritage therapeutic oils and creams, 100+ year Australian brand, marketing rights acquired 2011), and Minoxidil (topical OTC hair-loss treatment).
The company's technology base is pharmaceutical formulation development and generic-drug manufacturing, with quality standards meeting Australian Therapeutic Goods Administration (TGA) requirements equivalent to originator brands. Its go-to-market is a B2B distribution-led model: enterprise field sales to hospitals, channel relationships with pharmacy chains, and licensed out-licensing/in-licensing operations — generating revenue through unit sales of PBS-reimbursed generics, OTC consumer health products, hospital injectables, and licensing royalties. Headcount sits in the 51-100 range and the business self-reports as one of the fastest-growing pharmaceutical companies in Australia, with approximately 100% revenue growth over the trailing twelve months.
Generic Health's growth has been built through a serial acquisition strategy: Bellwether Pharma (2007) for early generic supply, Max Pharma (2009) for specialty hospital generics, Goanna brand rights (2011), the controlling and then full takeover by Lupin (2008 majority, 2011 100%, 2012 formal acquisition), Horizon Hospital Healthcare injectable products (2019), and Southern Cross Pharma (2021). The company now operates as the Australian/New Zealand commercial arm of Lupin Group, leveraging global generics scale, sourcing, and pipeline depth while maintaining a portfolio-led Australian brand identity across prescription, hospital, and OTC channels.
Generic Health firmographics
Firmographics- Name
- Generic Health
- Legal name
- Generic Health Pty Ltd
- Website
- https://generichealth.com.au
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Generic Health Pty Ltd (trading as Lupin AU), a wholly-owned subsidiary of India's Lupin Limited, supplies generic prescription medicines, specialty injectable products, and over-the-counter brands (Pharmacy Action, Goanna, Minoxidil) to community pharmacies, public and private hospitals, and consumers across Australia and New Zealand.
- Ownership category
- akta.pro rank
Generic Health industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (4242)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)
- akta.pro secondary industries
- Sterile Injectable Generics (HLAIABAC), Specialty Care Pharmaceuticals (HLAIAAAB), Specialty Pharmaceutical Distributors (HLAIAJAB)
Keywords
Where Generic Health is headquartered
LocationHeadquarters
- HQ city
- Box Hill
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Generic Health business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others
Revenue model
- Prescription Generic Medicines: Generic prescription pharmaceuticals sold to patients through pharmacies, reimbursed under the Pharmaceutical Benefits Schedule (PBS) in Australia.
- Over-the-Counter Products: OTC pharmaceutical products sold directly to consumers through pharmacies, including the Pharmacy Action brand range.
- Hospital Injectable Products: Specialty injectable products supplied to public and private hospitals across Australia.
- Licensing: Out-licensing and in-licensing of pharmaceutical molecules and products to/from other pharmaceutical companies.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Generic Health product offering
Product offeringCore offering
Generic Health manufactures and supplies high-quality generic prescription medicines, specialty injectable products, and over-the-counter medicines to pharmacies and hospitals across Australia and New Zealand. The portfolio is sold under the Generic Health, Pharmacy Action, Goanna, and Minoxidil brands, with supply into public and private hospitals via dedicated account managers and into community pharmacies through distribution partnerships. The company also conducts in-licensing and out-licensing of pharmaceutical molecules and products with other pharmaceutical firms.
Product overview
Generic Health is a pharmaceutical company offering a comprehensive portfolio of generic prescription medicines, specialty injectable products, and over-the-counter medicines. The company's product ecosystem includes the core Generic Health brand (specialty injectables and prescription generics), Pharmacy Action (OTC range), Goanna (therapeutic oils and creams for pain relief), and Minoxidil (hair loss treatment). Hospital-specific products are also provided. The company focuses on launching off-patent molecules at PBS listing dates and maintains a commitment to quality standards equivalent to original brands while delivering cost savings to pharmacies, hospitals, and consumers.
Differentiator
Problem solved
Functional benefit
Brands
- Generic Health: Speciality injectables and oral products, and generic prescription products available to patients in local pharmacies.
- Pharmacy Action
- Goanna
- Minoxidil
Products and services
- Generic Health Brand Specialty injectables and oral generic prescription products made available to patients through local pharmacies and supplied to hospitals; products and manufacturing facilities meet the same strict standards as the original brand, offered at competitive value.
- Pharmacy Action Comprehensive range of over-the-counter (OTC) pharmaceutical products available in pharmacies across Australia, positioned as a cost-effective alternative to original brands while maintaining comparable quality, safety, and efficacy standards.
- Goanna Premium therapeutic oils and creams trusted by Australians for over 100 years, combining Australian ingredients with modern pharmaceutical research to provide temporary relief from muscular aches and pains and mild arthritis symptoms.
- Minoxidil Over-the-counter topical minoxidil (5%) hair loss treatment for men and women in Australia for androgenetic alopecia (male and female pattern hair loss), promoting hair growth via improved blood flow and activation of biological pathways in hair follicles.
- Hospital Portfolio Prescription products in both injectable and oral dosage forms supplied to public and private hospitals across Australia, meeting the strict quality standards of Generic Health products while offering excellent value to hospital formularies.
Quantifiable outcome
- Nearly 100% revenue growth in past 12 months
- +1 more outcomes
Companies that use Generic Health
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles3 records
Generic Health technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Generic Health partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered minor and core.
- Southern Cross Pharma Pty LtdminorAcquired Southern Cross Pharma Pty Ltd in 2021 as part of ongoing expansion strategy.
- Horizon Hospital HealthcareminorAcquired a range of injectable products from Horizon Hospital Healthcare in 2019, expanding the hospital portfolio.
- Goanna BrandcoreAcquired marketing rights to the Goanna brand of therapeutic creams, rubs and oils in 2011, a trusted Australian brand with over 100 years of heritage.
- Max Pharma Pty LtdcoreAcquired in 2009, Max Pharma expanded Generic Health's product portfolio to include specialty hospital generics.
- Bellwether Pharma LtdcoreAcquired in 2007, Bellwether Pharma was a supplier of quality generic pharmaceuticals that strengthened Generic Health's early business foundations.
- Australian Packaging Covenant Organisation (APCO)minorBecame a member of APCO in 2020, committed to working towards achieving the 2025 National Packaging Targets and ensuring packaging materials are reusable, renewable, or recyclable.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Generic Health competitors and assessment
Company assessmentDirect peers
- Alphapharm (Viatris): Australian generic pharmaceutical subsidiary of Viatris, one of the largest suppliers of prescription generics in Australia. Most direct head-to-head competitor for Generic Health in Australian PBS-reimbursed prescription generics and pharmacy distribution.
- Apotex: Canadian-headquartered generic pharmaceutical manufacturer with significant Australian operations. Competes directly with Generic Health in the Australian generic prescription market across multiple therapeutic categories distributed through the same pharmacy and hospital channels.
- Mayne Pharma: Australian specialty pharmaceutical company focused on branded and generic prescription products. Directly comparable as an ANZ-headquartered competitor with overlapping generics and specialty product portfolios targeting similar pharmacy and hospital customers.
- Arrotex Pharmaceuticals: Australia's largest generic pharmaceutical company by volume, formed via acquisition of multiple local generic businesses. Directly competes with Generic Health in prescription generics and OTC categories across Australian community pharmacy channels.
Regional players
- Ego Pharmaceuticals: Australian privately-held pharmaceutical company specializing in dermatology and OTC skincare products. Comparable in the ANZ OTC consumer health segment where Generic Health's Pharmacy Action and Goanna brands compete.
- AFT Pharmaceuticals: Australia and New Zealand-headquartered specialty pharmaceutical company with both OTC and prescription products. Overlaps with Generic Health's OTC portfolio (Pharmacy Action, Goanna) and operates in the same ANZ geographies.
Broad incumbents
- Viatris: Global pharmaceutical company formed from Mylan-Upjohn combination with substantial generic and specialty portfolio. Competes with Generic Health in Australian prescription generics, specialty injectables, and hospital channel.
- Teva Pharmaceutical Industries: World's largest generic pharmaceutical manufacturer with operations across most major markets including Australia. Competes broadly with Generic Health across generic prescription categories and specialty products.
- Sandoz (Novartis): Global generic and biosimilar division of Novartis, one of the largest generic players worldwide. Operates in the Australian generic prescription market as a broad incumbent competing with Generic Health across multiple molecule categories.
- Cipla Australia: Australian subsidiary of Indian global generic major Cipla. Competes with Generic Health in Australian prescription generics and respiratory/injectable categories, backed by similar parent-company scale economics.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Generic Health social profiles
Digital presenceGeneric Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Generic Health leadership team
Management profileNumber of profiles
Profiles1 record
Generic Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Generic Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Generic Health
What does Generic Health do?
Generic Health manufactures and supplies high-quality generic prescription medicines, specialty injectable products, and over-the-counter medicines to pharmacies and hospitals across Australia and New Zealand. The portfolio is sold under the Generic Health, Pharmacy Action, Goanna, and Minoxidil brands, with supply into public and private hospitals via dedicated account managers and into community pharmacies through distribution partnerships. The company also conducts in-licensing and out-licensing of pharmaceutical molecules and products with other pharmaceutical firms.
Is Generic Health a public or private company?
Generic Health is a private company. It is classified as corporate owned and is currently operating.
When was Generic Health founded?
Generic Health was founded in 2004. It employs 11 to 50 people.
Where is Generic Health based?
Generic Health is headquartered in Box Hill, Australia, in the Oceania region.
How does Generic Health make money?
Four revenue lines are on record. Prescription Generic Medicines are the primary driver. The others are over-the-Counter Products, hospital Injectable Products and licensing.
Who are Generic Health's main competitors?
Direct peers on record are Alphapharm (Viatris), Apotex, Mayne Pharma and Arrotex Pharmaceuticals. Regional players are Ego Pharmaceuticals and AFT Pharmaceuticals. Broad incumbents are Viatris, Teva Pharmaceutical Industries, Sandoz (Novartis) and Cipla Australia.
Does Generic Health have an API?
No public API is recorded for Generic Health.
What industry is Generic Health in?
Generic Health's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAA, Small-Molecule Generics (Branded/Unbranded), with a secondary code of HLAIABAC, Sterile Injectable Generics. Its NAICS code is 32541 and its SIC code is 2834.